Octreotide acetate (USAN)

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

61 API Suppliers, 26 USDMF, 9 CEP/COS, 4 JDMF, 8 EU WC, 1 KDMF, 20 NDC API, 33 Listed Suppliers

DEVELOPMENTS

48 Drugs in Development

48 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

379 FDF Dossiers, 64 FDA Orange Book, 222 Europe, 14 Canada, 48 Australia, 8 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 0.05MG BASE/ML, INJECTABLE;INJECTION - EQ 0.1MG BASE/ML, INJECTABLE;INJECTION - EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 0.5MG BASE/ML, INJECTABLE;INJECTION - EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;SUBCUTANEOUS - EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 14 SPI Pharma, 1 Gangwal Healthcare, 1 Pfanstiehl, 3 Kirsch Pharma, 3 Dr. Paul Lohmann GmbH & Co. KGaA, 2 Actylis, 1 BASF, 1 Finar, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 1 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 12 Chewable & Orodispersible Aids, 10 Direct Compression, 10 Taste Masking, 10 Parenteral, 7 Disintegrants & Superdisintegrants, 4 API Stability Enhancers, 3 Granulation, 3 Co-Processed Excipients, 1 Thickeners and Stabilizers, 1 Solubilizers, 1 Topical

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 44 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions, 47 Regulatory FDF Prices, 11 Annual Reports

MARKET PLACE

20 APIs, 16 FDF Dossiers

PATENTS & EXCLUSIVITIES

29 US Patents, 4 US Exclusivities, 7 Health Canada Patents

REF. STANDARDS & IMPURITIES

6 Others

6 Others

Xls

Filters

Octreotide Acetate (USAN)

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Finar

filter Capability Reset all filters

filter Country Reset all filters

01

Finar

L-(+)-LACTIC ACID

Sampe

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for Octreotide acetate (USAN)? Find Topical used in Octreotide acetate (USAN) to address drug delivery challenges on PharmaCompass.

Octreotide acetate (USAN)

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

61 API Suppliers

26 USDMF

9 CEP/COS

4 JDMF

8 EU WC

1 KDMF

20 NDC API

33 Listed Suppliers

DEVELOPMENTS

48 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

379 FDF Dossiers

64 FDA Orange Book

222 Europe

14 Canada

48 Australia

8 South Africa

23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 0.05MG BASE/ML

INJECTABLE;INJECTION - EQ 0.1MG BASE/ML

INJECTABLE;INJECTION - EQ 0.2MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 0.5MG BASE/ML

INJECTABLE;INJECTION - EQ 1MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;SUBCUTANEOUS - EQ 7MG BASE/2.8ML (EQ 2.5MG BASE/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

14 SPI Pharma

1 Gangwal Healthcare

1 Pfanstiehl

3 Kirsch Pharma

3 Dr. Paul Lohmann GmbH & Co. KGaA

2 Actylis

1 BASF

1 Finar

2 Gangwal Chemicals

1 Ingredion Pharma Solutions

1 Kerry

2 Microlex e.U

1 Pluviaendo

3 Roquette

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders

12 Chewable & Orodispersible Aids

10 Direct Compression

10 Taste Masking

10 Parenteral

7 Disintegrants & Superdisintegrants

4 API Stability Enhancers

3 Granulation

3 Co-Processed Excipients

1 Thickeners and Stabilizers

1 Solubilizers

1 Topical

DIGITAL CONTENT

2 Data Compilation #PharmaFlow

44 News #PharmaBuzz

GLOBAL SALES INFORMATION

12 US Medicaid Prescriptions

47 Regulatory FDF Prices

11 Annual Reports

MARKET PLACE

20 APIs

16 FDF Dossiers

PATENTS & EXCLUSIVITIES

29 US Patents

4 US Exclusivities

7 Health Canada Patents

REF. STANDARDS & IMPURITIES

INJECTABLE;INJECTION - EQ 0.2MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 1MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons